| pubmed-article:11938035 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11938035 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:11938035 | lifeskim:mentions | umls-concept:C0010346 | lld:lifeskim |
| pubmed-article:11938035 | lifeskim:mentions | umls-concept:C0004482 | lld:lifeskim |
| pubmed-article:11938035 | lifeskim:mentions | umls-concept:C0025677 | lld:lifeskim |
| pubmed-article:11938035 | lifeskim:mentions | umls-concept:C0209368 | lld:lifeskim |
| pubmed-article:11938035 | lifeskim:mentions | umls-concept:C0231174 | lld:lifeskim |
| pubmed-article:11938035 | lifeskim:mentions | umls-concept:C0205269 | lld:lifeskim |
| pubmed-article:11938035 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:11938035 | pubmed:dateCreated | 2002-4-8 | lld:pubmed |
| pubmed-article:11938035 | pubmed:abstractText | Failure or intolerance of treatments by azathioprine (AZA) or methotrexate (MTX) is an important problem in the maintenance treatment of refractory CD. Results of the alternative use of mycophenolate mofetil (MMF) are conflicting. | lld:pubmed |
| pubmed-article:11938035 | pubmed:language | fre | lld:pubmed |
| pubmed-article:11938035 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11938035 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11938035 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11938035 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11938035 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11938035 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11938035 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11938035 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:11938035 | pubmed:issn | 0399-8320 | lld:pubmed |
| pubmed-article:11938035 | pubmed:author | pubmed-author:MarteauPhilip... | lld:pubmed |
| pubmed-article:11938035 | pubmed:author | pubmed-author:ModiglianiRob... | lld:pubmed |
| pubmed-article:11938035 | pubmed:author | pubmed-author:ColombelJean-... | lld:pubmed |
| pubmed-article:11938035 | pubmed:author | pubmed-author:CortotAntoine... | lld:pubmed |
| pubmed-article:11938035 | pubmed:author | pubmed-author:HafraouiSamir... | lld:pubmed |
| pubmed-article:11938035 | pubmed:author | pubmed-author:DewitOlivierO | lld:pubmed |
| pubmed-article:11938035 | pubmed:author | pubmed-author:CosnesJacques... | lld:pubmed |
| pubmed-article:11938035 | pubmed:author | pubmed-author:LémannMarcM | lld:pubmed |
| pubmed-article:11938035 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11938035 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:11938035 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11938035 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11938035 | pubmed:pagination | 17-22 | lld:pubmed |
| pubmed-article:11938035 | pubmed:dateRevised | 2009-11-3 | lld:pubmed |
| pubmed-article:11938035 | pubmed:meshHeading | pubmed-meshheading:11938035... | lld:pubmed |
| pubmed-article:11938035 | pubmed:meshHeading | pubmed-meshheading:11938035... | lld:pubmed |
| pubmed-article:11938035 | pubmed:meshHeading | pubmed-meshheading:11938035... | lld:pubmed |
| pubmed-article:11938035 | pubmed:meshHeading | pubmed-meshheading:11938035... | lld:pubmed |
| pubmed-article:11938035 | pubmed:meshHeading | pubmed-meshheading:11938035... | lld:pubmed |
| pubmed-article:11938035 | pubmed:meshHeading | pubmed-meshheading:11938035... | lld:pubmed |
| pubmed-article:11938035 | pubmed:meshHeading | pubmed-meshheading:11938035... | lld:pubmed |
| pubmed-article:11938035 | pubmed:meshHeading | pubmed-meshheading:11938035... | lld:pubmed |
| pubmed-article:11938035 | pubmed:meshHeading | pubmed-meshheading:11938035... | lld:pubmed |
| pubmed-article:11938035 | pubmed:meshHeading | pubmed-meshheading:11938035... | lld:pubmed |
| pubmed-article:11938035 | pubmed:meshHeading | pubmed-meshheading:11938035... | lld:pubmed |
| pubmed-article:11938035 | pubmed:meshHeading | pubmed-meshheading:11938035... | lld:pubmed |
| pubmed-article:11938035 | pubmed:meshHeading | pubmed-meshheading:11938035... | lld:pubmed |
| pubmed-article:11938035 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:11938035 | pubmed:articleTitle | [Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate]. | lld:pubmed |
| pubmed-article:11938035 | pubmed:affiliation | Services d'Hépato-Gastroentérologie, Hôpital Cl.-Huriez, Lille, Paris, France. | lld:pubmed |
| pubmed-article:11938035 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11938035 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11938035 | pubmed:publicationType | English Abstract | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11938035 | lld:pubmed |
